BIOLASE Inc represents values of innovation, excellence, and patient-centric care. With a strong corporate philosophy focused on transforming dental procedures, BIOLASE Inc is a leading dental laser technology company. They aim to deliver cutting-edge solutions that improve patient outcomes and enhance the dental experience. By leveraging their advanced products, such as Waterlase dental lasers, BIOLASE Inc enables minimally invasive and precise treatments, minimizing pain and promoting faster recovery. With a relentless commitment to research and development, BIOLASE Inc constantly pushes the boundaries of dental technology to ensure optimal oral health for patients worldwide.

BIOLASE Inc is primarily present in the United States.

BIOLASE Inc has achieved several significant milestones since its inception. The company pioneered the development and commercialization of dental laser systems, revolutionizing the dental industry. They introduced the world's first dental laser, the Waterlase system, which offers minimally invasive and precise treatments. Moreover, BIOLASE has gained FDA approvals for various dental laser applications, expanding their product portfolio. They have also established partnerships with renowned dental organizations and institutions worldwide. Additionally, BIOLASE has received multiple awards and accolades for its innovative technologies and contributions to the dental field. These achievements solidify BIOLASE Inc's position as a leading provider of dental laser systems and reinforce their commitment to advancing patient care.

BIOLASE Inc is a renowned company in the field of dental lasers and imaging technology. Established in 1987, it has garnered a strong reputation for its innovative products and solutions. With a focus on improving dental treatments, BIOLASE has developed advanced laser systems that revolutionize dental procedures. The company's commitment to research and development has led to numerous patented technologies, making BIOLASE a leader in the industry. Over the years, BIOLASE Inc has significantly contributed to the dental healthcare sector and continues to provide cutting-edge solutions for better patient outcomes.

The main competitors of BIOLASE Inc in the market are Dentsply Sirona Inc, Zimmer Biomet Holdings Inc, and Straumann Holding AG.

BIOLASE Inc is primarily active in the dental industry.

The business model of BIOLASE Inc revolves around developing, manufacturing, and marketing innovative dental laser systems. BIOLASE aims to provide superior solutions for dental practitioners worldwide, enabling minimally invasive and more efficient dental procedures. Known for their flagship product, Waterlase, BIOLASE utilizes laser technology to deliver precise and gentle dental treatments, reducing the need for drills, anesthesia, and pain. With a focus on improving patient care and outcomes, BIOLASE's business model centers on advancing dental laser technology and expanding their market presence through strategic partnerships and continuous innovation.

BIOLASE KGV ir -0,00.

BIOLASE KUV ir 0,00.

AlleAktien kvalitātes vērtējums BIOLASE ir 4/10.

gaidāmā BIOLASE apgrozījums ir 51,69 milj. USD.

gaidāmā BIOLASE peļņa ir -16,43 milj. USD.

BIOLASE Inc is a leading company in medical technology that specializes in the development, manufacturing, and marketing of laser systems for dentistry and other medical applications. The company was founded in 1987 and is headquartered in Irvine, California. BIOLASE's focus is on developing dental lasers that enable gentle and pain-free treatment of patients. The main division of BIOLASE is the development of laser systems for dentistry. The company offers a wide range of products such as Waterlase systems, Epic diode lasers, and diagnostic equipment. The Waterlase systems use water and laser energy to soften tooth hardness and enable pain-free treatment. The Epic diode lasers specialize in the treatment of gum diseases and provide a fast and effective treatment method. The diagnostic equipment allows for accurate diagnosis of dental problems and thus speeds up the healing process. BIOLASE is also active in other medical fields, such as pain and inflammation treatment. The company offers a variety of laser systems that can be used in pain treatment and inflammation reduction. These systems are capable of targeting specific areas in the body, leading to faster and more effective healing. Another business area of the company is research and development of new technologies. BIOLASE heavily invests in the development of new laser systems and technologies to expand treatment options for dentists and other medical professionals. The company works closely with doctors and dentists to understand customer requirements and needs and to find innovative solutions that meet the needs of patients. BIOLASE also operates an extensive network of distribution partners and distribution centers in various countries worldwide. The company has built a global distribution network to ensure that its products are available in different markets worldwide. BIOLASE works closely with its distribution partners to ensure that its customers receive the best products and services. Overall, BIOLASE Inc is a leading company in medical technology that specializes in the development and marketing of laser systems for dentistry and other medical applications. The company is at the forefront of developing new and innovative technologies and works closely with its customers and distribution partners to provide the best possible products and services.

BIOLASE izmaksā dividendes 0 USD, kas tiek izmaksātas reizes gadā.

Dividendes pašlaik nevar aprēķināt BIOLASE vai uzņēmums nedod dividendes.

BIOLASE ISIN ir US0909112072.

BIOLASE WKN ir 894190.

BIOLASE simbols ir BIOL.

Pēdējo 12 mēnešu laikā BIOLASE maksāja dividendes 0,14 USD apmērā. Tas atbilst aptuveni 247,43 % dividendes ražībai. Nākamajos 12 mēnešos BIOLASE plāno maksāt dividendes 0 USD apmērā.

BIOLASE pašreizējā dividendu rentabilitāte ir 247,43 %.

BIOLASE maksā dividendes ceturksnī. Tās tiek izmaksātas mēnešos janvāris, marts, maijs, jūlijs.

BIOLASE pēdējo 0 gadu laikā katru gadu izmaksāja dividendes.

Nākamajiem 12 mēnešiem tiek prognozētas dividendes apmērā 0 USD. Tas atbilst dividendes ražībai 0 %.

BIOLASE tiek piešķirts nozarei "Veselība".

Lai saņemtu pēdējo dividendu BIOLASE apmērā 0,01 USD, kas tika izmaksāta 12.07.2005., tev akcija bija jāpatur depozītā līdz Ekss dienai, kas bija 24.06.2005..

Pēdējās dividendes izmaksa notika 12.07.2005..

Gadā 2023, BIOLASE izmaksāja 0 USD dividendes.

BIOLASE dividendes tiek izmaksātas USD.